Product
Help
Pricing
About
Jobs
Log in
Get started
Author
Add to collection
Shuyang Mao
Institutions:
University of Shanghai for Science and Technology,
Shanghai University of Medicine and Health Sciences
Observed institutions:
University of Shanghai for Science and Technology,
Jiading District Central Hospital,
Shanghai University of Medicine and Health Sciences
ORCID:
0009-0002-8955-7798
Observed ORCID:
0009-0002-8955-7798
OpenAlex ID:
A5023980742
Frizzled‐7‐targeting antibody (SHH002‐hu1) potently suppresses non–small‐cell lung cancer via Wnt/β‐catenin signaling
2023
·
Kanghua Li
, Shuyang Mao
, et al.
·
Cancer Science
·
20
PDF
Frizzled-7-targeting antibody-derived bifunctional protein retargets NK cells against triple-negative breast cancer cells via MICA-NKG2D axis
2025
·
Chenyue Wang
, Lisha Wu
, et al.
·
Journal for ImmunoTherapy of Cancer
·
13
Targeted protein degradation of Wnt/β-catenin signaling pathway: an effective strategy for cancer therapy
2025
·
Shuyang Mao
, Xiaofan Zhang
, et al.
·
Journal of Translational Medicine
·
12
PDF
Integrating CAR-T therapy with PD-1/PD-L1 blockade: Mechanisms, synergy, and optimized strategies in NSCLC
2026
·
Xingxing Li
, Zitong Wang
, et al.
·
iScience
·
7
A novel bispecific antibody targeting Frizzled7/PD-L1 overcomes NSCLC resistance to atezolizumab by reprogramming tumor microenvironment
2026
·
Shuyang Mao
, Xiaofan Zhang
, et al.
·
npj Precision Oncology
PDF
Dual-recognizing antibodies targeting CEACAMs in the tumor microenvironment: towards more precise targeting
2026
·
Jiayi Ye
, Yijun Zhao
, et al.
·
Cell Communication and Signaling
Show more works
View as search
Works count:
6
Citation count:
52
H-index:
4
I10-index:
3
Year
Topic
Type